Advancing the Science and Practice of Medication Adherence

Medication adherence remains a significant unmet challenge for optimizing patient outcomes. Recent advances in the conceptualization, measurement, and support of medication adherence offer fresh opportunities to make a meaningful impact on adherence-related behavior and outcomes. These advances emphasize the multifaceted and dynamic nature of medication adherence, provide novel methods for monitoring medication adherence in clinical care, and articulate a set of multilevel strategies to more effectively improve and sustain medication adherence. Here, we offer recommendations for how clinicians can better engage with, and benefit from, these innovations to improve patient medication adherence and associated treatment outcomes.

[1]  Jeffrey I. Campbell,et al.  Cell Phone-Based and Adherence Device Technologies for HIV Care and Treatment in Resource-Limited Settings: Recent Advances , 2015, Current HIV/AIDS Reports.

[2]  P. Cahn,et al.  Improving Adherence to Care Among “Hard to Reach” HIV-Infected Patients in Argentina , 2016, AIDS and Behavior.

[3]  Marsha A Raebel,et al.  Measurement of Adherence in Pharmacy Administrative Databases: A Proposal for Standard Definitions and Preferred Measures , 2006, The Annals of pharmacotherapy.

[4]  C. Vogeli,et al.  Primary Medication Non-Adherence: Analysis of 195,930 Electronic Prescriptions , 2010, Journal of General Internal Medicine.

[5]  M. Chesney,et al.  The Elusive Gold Standard: Future Perspectives for HIV Adherence Assessment and Intervention , 2006, Journal of acquired immune deficiency syndromes.

[6]  Using Adherence Information to Improve Care: From Clinic Visits to Populations , 2016, Journal of General Internal Medicine.

[7]  T. Henry,et al.  Persistence with secondary prevention medications after acute myocardial infarction: Insights from the TRANSLATE-ACS study. , 2015, American heart journal.

[8]  J. Arnsten,et al.  Practical and Conceptual Challenges in Measuring Antiretroviral Adherence , 2006, Journal of acquired immune deficiency syndromes.

[9]  J. Tesoriero,et al.  Changes in Stress, Substance Use and Medication Beliefs are Associated with Changes in Adherence to HIV Antiretroviral Therapy , 2011, AIDS and Behavior.

[10]  T. Brennan,et al.  Effect of Reminder Devices on Medication Adherence: The REMIND Randomized Clinical Trial , 2017, JAMA internal medicine.

[11]  Jeffrey K Aronson,et al.  A new taxonomy for describing and defining adherence to medications. , 2012, British journal of clinical pharmacology.

[12]  W. Chaplin,et al.  An Electronic Adherence Measurement Intervention to Reduce Clinical Inertia in the Treatment of Uncontrolled Hypertension: The MATCH Cluster Randomized Clinical Trial , 2016, Journal of General Internal Medicine.

[13]  N. Samani,et al.  Risk Factors for Nonadherence to Antihypertensive Treatment , 2017, Hypertension.

[14]  J. Benner,et al.  Comparing Adherence and Persistence Across 6 Chronic Medication Classes , 2009, Journal of managed care pharmacy : JMCP.

[15]  A. Beck,et al.  Health system factors and antihypertensive adherence in a racially and ethnically diverse cohort of new users. , 2013, JAMA internal medicine.

[16]  L. Hurley,et al.  Determination of Optimized Multidisciplinary Care Team for Maximal Antiretroviral Therapy Adherence , 2012, Journal of acquired immune deficiency syndromes.

[17]  R. Anguiano,et al.  Medication adherence and persistence over time with self-administered TNF-alpha inhibitors among young adult, middle-aged, and older patients with rheumatologic conditions. , 2017, Seminars in arthritis and rheumatism.

[18]  A. Phillips,et al.  Long-term trends in adherence to antiretroviral therapy from start of HAART , 2010, AIDS.

[19]  D. Thompson,et al.  Direct Adherence Measurement Using an Ingestible Sensor Compared With Self-Reporting in High-Risk Cardiovascular Disease Patients Who Knew They Were Being Measured: A Prospective Intervention , 2017, JMIR mHealth and uHealth.

[20]  W. Jack,et al.  Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial , 2010, The Lancet.

[21]  Kenneth J. Ruggiero,et al.  Evaluation of an mHealth Medication Regimen Self-Management Program for African American and Hispanic Uncontrolled Hypertensives , 2015, Journal of personalized medicine.

[22]  C. Voils,et al.  Improving the measurement of self-reported medication nonadherence. , 2011, Journal of clinical epidemiology.

[23]  Jeffrey S. Gonzalez,et al.  Methodological Issues in the Assessment of Diabetes Treatment Adherence , 2011, Current diabetes reports.

[24]  J. Ralston,et al.  HIV Provider Documentation and Actions Following Patient Reports of At-risk Behaviors and Conditions When Identified by a Web-Based Point-of-Care Assessment , 2017, AIDS and Behavior.

[25]  Richard D Moore,et al.  Which Clinician Questions Elicit Accurate Disclosure of Antiretroviral Non-adherence When Talking to Patients? , 2016, AIDS and Behavior.

[26]  I. Wilson,et al.  Evaluation of the Single-Item Self-Rating Adherence Scale for Use in Routine Clinical Care of People Living with HIV , 2012, AIDS and Behavior.

[27]  B. Given,et al.  Title : mHealth SMS Text Messaging Interventions and to Promote Medication Adherence : An Integrative Review Concise Title : Adherence and Text Messaging , 2017 .

[28]  G. Mancia,et al.  The polypill in cardiovascular prevention: evidence, limitations and perspective - position paper of the European Society of Hypertension. , 2017, Journal of hypertension.

[29]  M. Dimatteo.  Variations in Patients’ Adherence to Medical Recommendations: A Quantitative Review of 50 Years of Research , 2004, Medical care.

[30]  W. Self,et al.  Systolic Blood Pressure and Biochemical Assessment of Adherence: A Cross-Sectional Analysis in the Emergency Department , 2017, Hypertension.

[31]  P. Weiden,et al.  Usability of a novel digital medicine system in adults with schizophrenia treated with sensor-embedded tablets of aripiprazole , 2016, Neuropsychiatric disease and treatment.

[32]  T. Brennan,et al.  Eliminating medication copayments reduces disparities in cardiovascular care. , 2014, Health affairs.

[33]  J. Steiner.  Self-reported adherence measures: what do they assess and how should we use them? , 2012, Medical care.

[34]  Roy H Perlis,et al.  First experience with a wireless system incorporating physiologic assessments and direct confirmation of digital tablet ingestions in ambulatory patients with schizophrenia or bipolar disorder. , 2013, The Journal of clinical psychiatry.

[35]  William Coady,et al.  Provider-Focused Intervention Increases Adherence-Related Dialogue but Does Not Improve Antiretroviral Therapy Adherence in Persons With HIV , 2010, Journal of acquired immune deficiency syndromes.

[36]  S. Antoniou,et al.  Current Situation of Medication Adherence in Hypertension , 2017, Front. Pharmacol..

[37]  T. Brennan,et al.  Group-based Trajectory Models: A New Approach to Classifying and Predicting Long-Term Medication Adherence , 2013, Medical care.

[38]  Peter J. Neumann,et al.  Long-term persistence in use of statin therapy in elderly patients. , 2002, JAMA.

[39]  George M. Savage,et al.  An Ingestible Sensor for Measuring Medication Adherence , 2015, IEEE Transactions on Biomedical Engineering.

[40]  Elizabeth Manias,et al.  Initial Medication Adherence-Review and Recommendations for Good Practices in Outcomes Research: An ISPOR Medication Adherence and Persistence Special Interest Group Report. , 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[41]  A. Burden,et al.  Measuring and improving adherence to osteoporosis pharmacotherapy , 2010, Current opinion in rheumatology.

[42]  A V Prochazka,et al.  The assessment of refill compliance using pharmacy records: methods, validity, and applications. , 1997, Journal of clinical epidemiology.

[43]  Bradley N Gaynes,et al.  Prescription refill records as a screening tool to identify antidepressant non‐adherence , 2010, Pharmacoepidemiology and drug safety.

[44]  W. Nilsen,et al.  Self-report measures of medication adherence behavior: recommendations on optimal use , 2015, Translational behavioral medicine.

[45]  P. Denig,et al.  Comparison of various measures for assessing medication refill adherence using prescription data , 2009, Pharmacoepidemiology and drug safety.

[46]  Bradi B Granger,et al.  Coming full circle in the measurement of medication adherence: opportunities and implications for health care , 2017, Patient preference and adherence.

[47]  W. Shrank,et al.  The impact of a retail prescription synchronization program on medication adherence. , 2017, Journal of the American Pharmacists Association : JAPhA.

[48]  L. Osterberg,et al.  Adherence to medication. , 2005, The New England journal of medicine.

[49]  P. Lavori,et al.  Shared treatment decision making improves adherence and outcomes in poorly controlled asthma. , 2010, American journal of respiratory and critical care medicine.

[50]  J. Urquhart,et al.  Adherence to medications: insights arising from studies on the unreliable link between prescribed and actual drug dosing histories. , 2012, Annual review of pharmacology and toxicology.

[51]  I. Kronish,et al.  In Search of a "Magic Pill" for Medication Nonadherence. , 2017, JAMA internal medicine.

[52]  A. Westfall,et al.  Improving the Prediction of Medication Compliance: The Example of Bisphosphonates for Osteoporosis , 2009, Medical care.

[53]  S. Siegel.  Extended release drug delivery strategies in psychiatry: theory to practice. , 2005, Psychiatry (Edgmont (Pa. : Township)).

[54]  R. Remien,et al.  Heterogeneity Among Studies in Rates of Decline of Antiretroviral Therapy Adherence Over Time: Results From the Multisite Adherence Collaboration on HIV 14 Study , 2013, Journal of acquired immune deficiency syndromes.

[55]  K. Lohr,et al.  Interventions to Improve Adherence to Self-administered Medications for Chronic Diseases in the United States , 2012, Annals of Internal Medicine.

[56]  C. Bova,et al.  An Analysis of Electronically Monitored Adherence to Antiretroviral Medications , 2010, AIDS and Behavior.

[57]  R B Haynes,et al.  Interventions for enhancing medication adherence. , 2008, The Cochrane database of systematic reviews.

[58]  N. Choudhry,et al.  Prevalence, effectiveness, and characteristics of pharmacy-based medication synchronization programs. , 2016, The American journal of managed care.

[59]  K. Chan,et al.  Comparison of Drug Adherence Rates Among Patients with Seven Different Medical Conditions , 2008, Pharmacotherapy.

[60]  Hayden B Bosworth,et al.  Medication adherence: A practical measurement selection guide using case studies. , 2017, Patient education and counseling.

[61]  P. Anderson,et al.  Application of an intracellular assay for determination of tenofovir-diphosphate and emtricitabine-triphosphate from erythrocytes using dried blood spots. , 2016, Journal of pharmaceutical and biomedical analysis.

[62]  L. Denson,et al.  Longitudinal Patterns of Medication Nonadherence and Associated Health Care Costs , 2017, Inflammatory bowel diseases.